猪源链球菌溶血性的检测*

用平板法和上清法检测了 1 9株猪源链球菌的溶血性 ,并通过加入还原剂或氧化剂分别作活化和抑制试验 ,对各菌株溶血素的性质做了初步鉴定。其中 8株猪链球菌 2型菌株在血平板上的溶血性较弱 ,仅为α溶血或弱 β溶血 ,但在THB和 5 %血清THB中都可产生很强的溶血性 ,其溶血性可被还原剂活化 ,被氧化剂和胆固醇所抑制 ,卵磷脂对其活性则没有影响 ,属于巯基活化类 (类SLO)溶血素。 9株马链球菌兽疫亚种菌株在血平板上呈显著的 β溶血 ,在不含血清THB中不能产生溶血性 ,在含血清的THB中可产生较强的     

透明质酸生产菌溶血素S基因缺失突变菌株的构建及其特性北大核心CSCD

【目的】马链球菌兽疫亚种是工业上生产透明质酸的主要菌种,该菌能产生引起宿主细胞溶血的链球菌溶血素S(streptolysin S,SLS)毒素,因而其产品的安全性一直是人们所担心的问题。本实验的目的就是通过基因敲除的方法构建不产SLS的透明质酸生产工程菌,同时探讨溶血素sag A基因缺失对菌株透明质酸合成和其他毒力因子的影响。【方法】利用温度敏感/自杀性质粒p JR700载体系统,构建马链球菌兽疫亚种sag A基因缺失突变株;通过PCR扩增,溶血平板和SLS含量测定等方法确定sag A基因缺失;采用分光光度、SDS-PAGE和细胞毒性试验等分析方法,对野生菌株和sag A基因缺失突变菌株透明质酸含量、透明质酸分子量、溶血素Hylc、透明质酸分解酶、甘油醛-3-磷酸脱氢酶和菌体表面蛋白等相关毒力因子进行对比研究。【结果】获得了透明质酸产量提高30%而溶血活性极低的马链球菌兽疫亚种sag A基因缺失突变株。该突变株与野生菌株相比较,透明质酸分解酶活性增加而透明质酸相对分子量降低,此外,与毒力相关的表面蛋白含量、溶血素Hylc和甘油醛-3-磷酸脱氢酶活性也显著降低。细胞毒性实验结果表明,野生菌株与sag A基因缺失突变菌株的培养物上清液,对细胞活性的影响存在显著差异。【结论】在马链球菌兽疫亚种中sag A不仅是表达溶血素SLS的基因,同时sag A基因对菌株透明质酸合成、透明质酸分解酶、菌体表面蛋白、溶血素Hylc和甘油醛-3-磷酸脱氢酶等都具有调节作用。     

羊源肠球菌溶血性的检测

[目的]了解羊源肠球菌溶血素的特性.[方法]以平板法、接触法、培养法、上清法及PCR法,对11株肠球菌临床分离株、30株健康羊分离株、肠球菌参考株和G群链球菌参考株进行了溶血性检测.[结果]接触法和上清法均不能检测到11株肠球菌临床分离株对兔血和羊血的溶血;平板法和培养法测得11株肠球菌临床分离株中,63.6%对兔血呈现β溶血,36.4%对羊血平板呈现α[溶血;基于检测cylA基因的PCR法,63.6%溶兔血菌能扩增出特异性条带,扩增产物序列与GenBank(L37110)中肠球菌同源性达99.3%.平板法测定30株健康羊分离株,初次分离培养53.3%对兔血β溶血,53.3%对羊血α溶血,43.3%对羊血β溶血,但二次传代后只有6%对兔血仍有溶血能力,且30株均不能检测到cylA.标准肠球菌对羊血平板有α溶血,而对兔血没有溶血性.[结论]提示肠球菌溶血性具有一定的溶血谱,不同检测方法检测的溶血情况不同;并且肠球菌溶血素必须在红细胞诱导下,通过细菌的生长繁殖产生;溶血素表型和基因型的检测不完全一致,对二者同时检测能提高肠球菌溶血素检测的准确性.     

化脓性链球菌溶血素O活性结构重组蛋白的制备

生物信息分析化脓性链球菌溶血素O(streptolysin O,Slo)蛋白结构表明,Slo蛋白除含有由461氨基酸残基组成的溶血活性结构域Thiol_cytolysin外,在N端还有一跨膜结构域。利用pET101-GENE蛋白表达系统,成功构建出表达具有Slo活性重组蛋白的重组子,采用镍柱亲和层析分离技术,纯化目的蛋白;纯化蛋白SDS-PAGE检测分析表明,重组蛋白与预测的溶血活性结构域的分子量相一致;溶血实验显示,纯化重组蛋白具有溶血活性。以纯化的重组蛋白为免疫原,对大鼠进行4次免疫,所获得免疫血清经 Elisa检测,抗Slo血清效价达到 1 ∶12 800;Western blot检测猪链球菌、马链球菌和化脓性链球菌中的链球菌溶血素结果显示,抗Slo多克隆抗体仅能与化脓性链球菌溶血素O发生反应,表明研究制备的化脓性链球菌溶血素O活性结构重组蛋白抗原具有较好的特异性,所制备的抗原Slo 可用于进一步开发抗链球菌溶血素O(ASO)试剂盒。     

肺炎链球菌溶血素及其生物学活性

<正> 早在80年前就已发现肺炎链球菌溶血素是肺炎链球菌产生的一种巯基激活的细胞溶素,但对其性质和在肺炎链球菌致病性中起的作用一直不清楚。生长在血琼脂平板上的肺炎链球菌菌落可以形成绿色的α溶血环,这种α溶血与肺炎球菌溶血素无关,已经证明加一滴纯化的肺炎球菌溶血素到血琼脂板上可以产生透明的β溶血。目前尚未有准确数据说明肺炎链球菌产生溶血素的频率,但发现从临床分离到的肺炎链球菌99％以上能产生这种溶血素。     

高龋菌株产生的变链素对口腔链球菌抑制活性的比较

目的 通过比较高龋和无龋儿童变形链球菌临床分离株产生的变链素对口腔链球菌的抑制活性,探讨变链素的产生与其致龋性及口腔微生态的关系.方法 从10例高龋儿童和10例无龋儿童牙菌斑内分离、鉴定得到80株变形链球菌临床分离株,分为高龋组和无龋组.用平板法检测两组菌株产生的变链素对口腔链球菌Streptococcus oralis ATCC 10557的抑制情况,观察两组菌株产生的抑菌环大小, 测量记录数据,T检验比较两组菌株抑菌环均数差异.结果 高龋组产生的抑菌环平均值为10.4 mm,无龋组平均值为6.9 mm,T检验显示差异具有显著性(t值为3.098,P<0.05).结论 高龋菌株产生的变链素对ATCC 10557有更大的抑制活性,变链素对口腔链球菌的抑制活性与其致龋力呈正相关.     

血链球菌细菌素抑菌活性研究

检测分离纯化的血链球菌细菌素对牙周可疑致病菌的抑制作用。通过羟基磷灰石(HA)柱层析、SephadexG-150凝胶柱层析、中空纤维柱超滤脱盐、浓缩纯化提取血链球菌细菌素,以具核梭杆菌为指示菌,洞平板法检测细菌素的抑菌活性。经HA柱层析得到4个相互分离的组分,经洞平板法检测,第Ⅱ峰的蛋白具有抑菌活性,冻干后得纯化后的细菌素,终产率为0.082%;1mg/mL的细菌素溶液可形成17mm的抑菌环,最小抑菌浓度为62.5μg/mL。血链球菌细菌素对牙周可疑致病菌具有较强的拮抗作用。     

肺炎链球菌溶血素的研究进展

肺炎链球菌溶血素(Pneumolysin,PLY)是肺炎链球菌的一种重要毒力因子,包含4个结构域,是胆固醇依赖性细胞溶血素(CDCs)的家族成员之一。PLY可广泛作用于宿主组织细胞,发挥细胞毒性作用。PLY可活化补体经典途径,诱导巨噬细胞和单核细胞等产生细胞因子,介导机体免疫应答过程。PLY是肺炎链球菌蛋白疫苗和相关小分子药物研制的重要靶标。本文就PLY的结构、功能及相关疫苗的最新研究进展进行综述。     

一种减毒肺炎链球菌溶血素突变体的构建与表达

目的使用重叠PCR方法构建构建△Al46Ply突变体,原核可溶性表达△Al46Ply蛋白,并明确其毒力变化情况;分析肺炎链球菌溶血素（pneumolysin,Ply）在不同血清型肺炎链球菌（streptococcus pneumoniae,SPN）中的表达情况。方法以SPND39型基因组DNA为模板设计合成构建突变体pry基因所需引物;利用重叠PCR方法扩增合成△Al46ply突变体。通过溶血实验分析其溶血活性,利用中和试验验证△A146Ply诱导产生的特异性抗体中和野生Ply毒素溶血能力,并利用Western印迹检测5株不同血清型肺炎链球菌流行菌株中Ply蛋白表达情况。结果突变体基因测序结果显示,Plyl46位密码子GCT3个碱基被缺失,△Al46ply突变体构建成功,并实现了△Al46Ply的可溶性表达,得到纯度〉90％的重组蛋白。△A146Ply蛋白浓度为100000ng／ml亦未表现出溶血活性。△Al46Ply蛋白诱导产生的特异性抗体能够中和野生Ply毒素的溶血活性。Western印迹结果显示,△Al46Ply诱导产生的多克隆抗体可与国内临床常见4株肺炎链球菌有交叉反应。结论△Al46Ply蛋白是一种安全的肺炎链球菌疫苗候选分子,可刺激机体产生具有中和作用的特异性抗体。     

β-溶血型链球菌与银屑病发病、发生及发展的研究现状

银屑病的发病与链球菌感染的相关性近年来得到人们的密切关注.银屑病是一类由T细胞介导的自身免疫性疾病,链球菌抗原可在易感人群中诱发或加重银屑病并使银屑病慢性持续存在.从β-溶血型链球菌诱发银屑病相关的细胞壁、细胞膜、CpG DNA序列及其他相关蛋白的自身抗原及β-溶血型链球菌通过活化T细胞、抗原抗体反应途径、通过作用机体的基因改变遗传易感性诱发银屑病的可能作用途径几方面,阐述β-溶血型链球菌与银屑病发病、发生及发展的研究现状.     

Identification of hemolysin BL-producing Bacillus cereus isolates by a discontinuous hemolytic pattern in blood agar.

Bacillus cereus causes distinct exotoxin-mediated diarrheal and emetic food poisoning syndromes and a variety of nongastrointestinal infections. Evidence is accumulating that hemolysin BL is a major B. cereus virulence factor. We describe two methods for detection of hemolysin BL in crude samples and on primary culture media. In the first method, the highly unusual discontinuous hemolysis pattern that is characteristic of pure hemolysin BL was produced in sheep and calf blood agar around wells filled with crude culture supernatant from hemolysin BL-producing strains. In the second method, the pattern was formed surrounding colonies of hemolysin BL-producing strains grown on media consisting of nutrient agar, 0.15 M NaCl, 2% calf serum, and sheep or calf blood. Hemolysin BL production was detected with these methods in 41 of 62 (66%) previously identified B. cereus isolates and in 46 of 136 (34%) presumptive B. cereus isolates from soil. All nine isolates tested that were associated with diarrhea or nongastrointestinal illness were positive for hemolysin BL. The methods presented here are specific, simple, inexpensive, and applicable to the screening of large numbers of samples or isolates.     

Similarities between complement-mediated and streptolysin S-mediated hemolysis

The oxygen-stable hemolysin streptolysin S (SLS) of Streptococcus pyogenes is encoded in part by the pel/sagA gene product. Antibodies to a synthetic peptide from the C terminus of the Pel/SagA open reading frame inhibited hemolysis mediated by both culture supernatants from multiple M serotypes of S. pyogenes isolates or a commercially available SLS preparation. Analysis of the SLS-mediated hemolytic reaction demonstrated that it was temperature- and concentration-dependent. Like complement-mediated hemolysis it conforms to the prediction of a one-hit mechanism of hemolysis. A number of intermediates in the SLS-mediated hemolysis of sheep erythrocytes could be distinguished. SLS could bind to erythrocytes below 17 degrees C; however, lysis could only occur at temperatures >23 degrees C. Following binding of SLS and washing, a papain-sensitive intermediate could be distinguished prior to insertion of the SLS complex into the erythrocyte membrane, which resulted in formation of a transmembrane pore and led to irreversible osmotic lysis of the cell. These intermediates were similar to those described previously during complement-mediated hemolysis.     

Cloning and expression in Escherichia coli and Bacillus subtilis of the hemolysin (cereolysin) determinant from Bacillus cereus.

From a cosmid gene bank of Bacillus cereus GP4 in Escherichia coli we isolated clones which, after several days of incubation, formed hemolysis zones on erythrocyte agar plates. These clones contained recombinant cosmids with B. cereus DNA insertions of varying lengths which shared some common restriction fragments. The smallest insertion was recloned as a PstI fragment into pJKK3-1, a shuttle vector which replicates in Bacillus subtilis and E. coli. When this recombinant plasmid (pJKK3-1 hly-1) was transformed into E. coli, it caused hemolysis on erythrocyte agar plates, but in liquid assays no external or internal hemolytic activity could be detected with the E. coli transformants. B. subtilis carrying the same plasmid exhibited hemolytic activity at levels comparable to those of the B. cereus donor strain. The hemolysin produced in B. subtilis seemed to be indistinguishable from cereolysin in its sensitivity to cholesterol, activation by dithiothreitol, and inactivation by antibodies raised against cereolysin. When the recombinant DNA carrying the cereolysin gene was used as a probe in hybridization experiments with chromosomal DNA from a streptolysin O-producing strain of Streptococcus pyogenes or from listeriolysin-producing strains of Listeria monocytogenes, no positive hybridization signals were obtained. These data suggest that the genes for these three SH-activated cytolysins do not have extended sequence homology.     

A low molecular weight enterotoxic hemolysin from clinical Enterobacter cloacae

Seven of 50 Enterobacter cloacae strains from clinical isolates produced small turbid zones of hemolysis in horse and sheep blood agar plates, and the culture supernatants were also positive for hemolytic activity. The hemolysin was partially purified from the culture supernatant of E. cloacae by ultrafiltration (PM-10 membrane) and extraction with acetone. Semipurified hemolysin was stable to heating (100 degrees C, 30 min) and was soluble in organic solvents (acetone, ethanol, and methanol). The toxin showed no loss of biological activity after treatment with trypsin and was stable to acid treatment at pH 2.0 but not at a pH greater than 7.0. In the rat intestinal loop assay, the hemolysin caused hemorrhagic fluid accumulation and severe histological alterations. These findings indicate that this hemolysin may be a putative virulence factor in E. cloacae infections.     

Action of streptolysin S, the group D hemolysin, and phospholipase C on whole cells and spheroplasts

Davie, Joseph M. (Indiana University, Bloomington), and Thomas D. Brock. Action of streptolysin S, the group D hemolysin, and phospholipase C on whole cells and spheroplasts. J. Bacteriol. 91:595-600. 1966.-The effect of streptolysin S, the group D hemolysin, and phospholipase C (the alpha toxin of Clostridium perfringens) on whole cells and spheroplasts or protoplasts of three strains of streptococci and Micrococcus lysodeikticus was tested. Viability, C(14)-glycine uptake, and lysis were measured. The group D hemolysin and phospholipase C were active against whole bacteria; streptolysin S was not. All three substances were active on spheroplasts. A partially resistant mutant derived from a strain sensitive to the group D hemolysin was also partially resistant to streptolysin S and phospholipase C. Antimycin A protected spheroplasts from streptolysin S but not from the group D hemolysin.     

几种芽胞杆菌溶血素BL基因及其溶血素的检测

用PCR方法对几种芽胞杆菌溶血素BL基因进行了检测,结果表明7株蜡样芽胞杆菌含有溶血素BL基因hblA、hblC、hblD,其他枯草芽胞杆菌、多粘类芽胞杆菌、地衣芽胞杆菌检测到部分溶血素基因;通过血平板培养的方法检测结果表明只有含有溶血素全部基因的菌株才会产生溶血环,从而为筛选不产生溶血素的有益芽胞杆菌奠定一定基础。     

COMPARATIVE KINETICS OF HEMOLYSIS INDUCED BY BACTERIAL AND OTHER HEMOLYSINS

A study has been made of the kinetics of lysis induced by various hemolytic agents. The course of bemolysis was followed by mixing lysin with washed human erythrocytes, removing samples from the mixture, and estimating colorimetrically the hemoglobin in the supernatant fluid of the centrifuged samples. Most of the curves (but not all of them, e.g. tyrocidine) obtained by plotting degree of hemolysis against time, were S-shaped. The initiation of lysis by streptolysin S'' was delayed, and in this property, streptolysin S'' was similar to Cl. septicum hemolysin. None of the other lysins studied exhibited a long latent period preceding lysis. The maximum rate of hemoglobin liberation was found, in the range of lysin concentrations studied, to be a linear function of concentration when theta toxin of Cl. welchii, pneumolysin, tetanolysin, or streptolysin S'' was the lytic agent. With comparable concentrations of saponin, sodium taurocholate, cetyl pyridinium chloride, tyrocidine, duponol C, lecithin-atrox venom mixture, or streptolysin O, the relation between rate and concentration was non-linear. The critical thermal increment associated with hemolysis was determined for systems containing pneumolysin, theta toxin, streptolysin S'', streptolysin O, tetanolysin, and saponin. The findings concerning the effect of concentration and temperature on the rate of hemolysis provide a basis for classifying hemolytic agents (Tables I and II). Hemolysis induced by Cl. septicum hemolysin was found to be preceded by two phases: a phase of alteration of the erythrocytes and a phase involving swelling. Antihemolytic serum inhibited the first but not the second phase while sucrose inhibited the second but not the first phase.     

An Escherichia coli-based bioengineering strategy to study streptolysin S biosynthesis

Group A Streptococcus pyogenes (GAS) is a leading human pathogen that produces a powerful cytolytic bacteriocin known as streptolysin S (SLS). We have developed a bioengineering strategy to successfully reconstitute SLS activity using heterologous expression in laboratory strains of Escherichia coli. Our E. coli-based heterologous expression system will allow more detailed studies into the biosynthesis of other bacteriocin compounds and the production of these natural products in much greater yield.     

Pneumococci Producing Beta Hemolysis on Agar

Fifty-six strains of pneumococci were studied for hemolysis on blood-agar Twenty-two (39%) of these strains produced beta hemolysis on agar containing horse red cells, six (11%) were beta hemolytic for sheep cells, and none lysed human or rabbit red cells. The substance producing beta hemolysis appeared after 24 hr of anaerobic incubation. Subsequent exposure to air at low temperature (6 to 20 C) for 48 hr was needed to activate it. There was no relation between serological type and beta hemolysis production. This substance appears to be different from the pneumococcal hemolysin previously described.